Scoping review about pathogenesis, risk factors, and treatment of venous and arterial thrombosis in coronavirus infection
Recognition of COVID-19-associated coagulopathy underscores the necessity of early risk stratification and individualized anticoagulation to mitigate thrombotic events and improve outcomes. Extended post-discharge prophylaxis appears promising in reducing late thrombotic complications. Future research should aim to refine optimal anticoagulant regimens and determine ideal prophylaxis duration for COVID-19-related thrombosis to reduce morbidity and mortality rates.
Institutions
- Applied Science Private University (JO)
- Inserm (FR)
- Lebanese University (LB)
- Gulf Medical University (AE)
- University of Nicosia (CY)
- Gulf University for Science & Technology (KW)
- Holy Spirit University of Kaslik (LB)
- Université Paris-Est Créteil (FR)
- Générale de Santé (FR)
- Institut de Recherche pour le Développement (FR)
- Lebanese American University (LB)
- Université de Limoges (FR)
- Lebanese International University (LB)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-12-12
- DOI
- https://doi.org/10.3389/fcvm.2025.1688115
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00